Navigation Links
Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
Date:11/1/2008

LR7 agonist prodrug. The Company is also developing ANA773 for the treatment of cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to (i) the belief that ANA598 is one of the leading non-nucleoside polymerase inhibitors currently in development for the treatment of HCV; (ii) the potential for ANA598 to be used in combination with multiple other agents approved or under investigation for hepatitis C; (iii) the potential for once-daily or twice-daily oral dosing of ANA598; (iv) the level of plasma drug concentration of ANA598 predicted to display antiviral potency; (v) the ability of Anadys to transition into Phase II studies of ANA598 during 2009; and (vi) expectations regarding the evolution of the market for HCV therapies. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 and ANA773 will not have unforeseen safety issues, will have favorable results in future clinical trials or will receive regulatory approval. In addition, Anadys' results may be affected by risks related to competition from other biotechnology and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its products, regulatory developments involving its product candidates and its ability to obtai
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
2. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
3. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
6. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
9. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
10. Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura
11. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 Northstar ... announced that after months of hard work from ... the new Snorenz formulation and package design.  The ... and B-6 back into the product due to ... longer lasting effects.  Snorenz Nighttime will also include ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine ... methamphetamine offenders and make arrests. Data released by ... blocked the sale of more than ...
Breaking Medicine Technology:Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... a Minnesota-based medical device company, has announced that they have ... F acilitated A ntegrade S teering T ... cclusions (PFAST-CTOs) study.  The company received approval from the FDA ... IDE for the peripheral devices and is now actively enrolling ...
... In a letter to Congressional Leadership, the Biotechnology ... Congress to support the U.S. Food and Drug Administration,s ... During House consideration of H.R. 2112, the ... Administration, and Related Agencies Appropriations Act, an amendment was ...
Cached Medicine Technology:BridgePoint Medical Announces US IDE Approval and First Patient Enrollment of Peripheral Chronic Total Occlusion Study 2Hill Leadership: Support Science-Based Assessments by FDA 2
(Date:8/22/2014)... Teen substance abuse has long been ... most young adults never receive the professional treatment they ... the new Troubled Teens Columbus helpline was established to ... their drug and alcohol dependencies . , ... their parents can speak directly to a representative who ...
(Date:8/22/2014)... Hills, CA (PRWEB) August 22, 2014 Dr ... Personal for this snoring cure. , In the October 2014 ... interview of Dr Grossan about his method of treating snoring, ... article quotes Dr Grossan: "Nearly half of all adults snore ... sleeping. This is because air passages in the back ...
(Date:8/21/2014)... 2014 Benefiting from accelerated aging ... expenses, the Chinese orthopedic instrument market demand has ... CAGR of 19.2% during 2009-2013. Trauma products, spine ... of orthopedic instruments in China, of which trauma ... in 2013. , Being optimistic about bright future ...
(Date:8/21/2014)... 2014 Strongly influenced by their ... when there are no consequences, researchers in Georgia ... , This could imply that humans are less ... others, researchers said. Their findings are published in ... sense of unfairness is affected by their self-interest, ...
(Date:8/21/2014)... 21, 2014 Local agencies in the ... discounts for specific protection plans, according to released insurer ... to quote life insurance from local agencies using its ... agents that appear inside of the national system are ... of price reviews this year. Adults who enter the ...
Breaking Medicine News(10 mins):Health News:New Helpline in Columbus Assists Troubled Teen Find Youth Rehab 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 3Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 4Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 2Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 3Health News:Life Insurance from Local Agents Now Priced Nationally Through Complimentary Tool Online 2
... your hair and nails don,t grow after death, report says , , ... your mind is the idea that you should drink at least ... may have nodded in agreement when someone mentioned scientific studies showing ... , And you may have lectured your children about the danger ...
... 20 Percent of Cost for New Hospital, SAN ... has reached its $50 million Capital Campaign,goal, the largest ... recent gift of $500,000 from the Stephen and Mary ... http://www.newscom.com/cgi-bin/prnh/20071220/DC10448 ), "It,s only fitting that ...
... ALEXANDRIA, Va., Dec. 20 New research,published in ... high risk,overweight adolescents, ages 10-15, can lose weight ... for other less healthy snack choices. The,study, "Weight ... Trial" describes the "Family Lifestyle and Overweight" (FLOW),Prevention ...
... Inc. (Amex: IMA ) a leading manufacturer ... and professional markets, today,announced that it will acquire ... a privately held drugs of abuse diagnostics and,testing ... Santa,Rosa, California primarily distributes rapid drugs of abuse ...
... Capital,Corporation (Nasdaq: MCGC ) today announced a second ... of Gould & Lamb, LLC by ABRY,Partners LLC., ... is unique to,the workers, compensation industry. The company has ... industry,since 2001. Having completed in excess of 40,000 MSAs, ...
... Hospitals are dangerous,places and the danger is even ... bone, temps are relied on more than usual, and ... Betsy McCaughey, Ph.D., Chairman of the Committee to Reduce ... the,country that hospital staff are eager to improve your ...
Cached Medicine News:Health News:Busting Medical Myths Even Doctors Believe 2Health News:Sharp HealthCare Foundation Reaches $50 Million Goal 2Health News:Sharp HealthCare Foundation Reaches $50 Million Goal 3Health News:Overweight Kids Lose Weight Eating Peanuts Every Day in School-Based Study 2Health News:Overweight Kids Lose Weight Eating Peanuts Every Day in School-Based Study 3Health News:Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory 2Health News:Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory 3Health News:MCG Capital Invests in Gould & Lamb 2Health News:How to Survive an Unexpected Trip to the Hospital During Christmas and New Years 2
EchoScan US-2500 is available in a single configuration or in combination with the A scan for maximum cost efficiency....
EchoScan US-3300 takes accurate axial length and corneal thickness measurements in either automatic or manual modes. It is available in a single configuration or in combination with the A scan for ma...
PremierEdge Stab Knives - 45....
... The Answer to Micro-Incision ... Technology With its unique ... microsurgical knife is ideal for ... creates reproducible incisions that allow ...
Medicine Products: